Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Differences between clinical trial efficacy and real-world effectiveness.

Davidson MH.

Am J Manag Care. 2006 Nov;12(15 Suppl):S405-11. Review.

2.

Therapy to reduce risk of coronary heart disease.

Rader DJ.

Clin Cardiol. 2003 Jan;26(1):2-8. Review.

3.

Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.

Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM.

Am J Cardiol. 2005 Aug 15;96(4):556-63.

PMID:
16098311
4.

Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemia.

Talbert RL; National Cholesterol Education Program Adult treatment panel III..

Am J Health Syst Pharm. 2003 Jul 1;60(13 Suppl 2):S3-8; quiz S25.

PMID:
12901024
5.

Treatment of dyslipidaemia in high-risk patients: too little, too late.

Barter P.

Int J Clin Pract Suppl. 2002 Jul;(130):15-9. Review.

PMID:
12296602
6.
7.
8.

Statins: balancing benefits, efficacy and safety.

Clearfield MB.

Expert Opin Pharmacother. 2002 May;3(5):469-77. Review.

PMID:
11996626
9.

The human and economic costs of undertreatment with statins.

Durrington P.

Int J Clin Pract. 2002 Jun;56(5):357-68. Review.

PMID:
12137445
11.
12.

Underidentification and undertreatment of dyslipidemia.

Clearfield MB.

J Am Osteopath Assoc. 2003 Jan;103(1 Suppl 1):S5-8.

PMID:
12572623
14.

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.

Arca M, Gaspardone A.

Drugs. 2007;67 Suppl 1:29-42. Review.

PMID:
17910519
15.

Combination therapy for dyslipidemia.

Spellman CW.

J Am Osteopath Assoc. 2003 Jan;103(1 Suppl 1):S9-11.

PMID:
12572624
16.

Non-high-density lipoprotein cholesterol: the forgotten therapeutic target.

Maki KC, Galant R, Davidson MH.

Am J Cardiol. 2005 Nov 7;96(9A):59K-64K; discussion 34K-35K. Review.

PMID:
16291016
17.

Approach to lipoprotein management in 2001 National Cholesterol Guidelines.

Grundy SM; National Cholesterol Education Program (NCEP)-The National Cholesterol Guidelines in 2001, Adult Treatment Panel (ATP) III..

Am J Cardiol. 2002 Oct 17;90(8A):11i-21i.

PMID:
12419477
18.

Risk of cardiovascular events in patients at optimal values for combined lipid parameters.

Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ.

Curr Med Res Opin. 2007 Mar;23(3):553-63.

PMID:
17357251
19.
20.

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

Mann D, Reynolds K, Smith D, Muntner P.

Ann Pharmacother. 2008 Sep;42(9):1208-15. doi: 10.1345/aph.1L181.

PMID:
18648016
Items per page

Supplemental Content

Support Center